ArticleCell transplantation2019

Transendocardial CD34+ Cell Therapy does not Increase the Risk of Ventricular Arrhythmias in Patients with Chronic Heart Failure.

Gregor Poglajen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.